"TBSF" Human Immunoglobulin for Intravenous Use

Land: Australien

Språk: engelska

Källa: Department of Health (Therapeutic Goods Administration)

Aktiva substanser:

normal immunoglobulin, Quantity: 60 g/L

Tillgänglig från:

CSL Behring Australia Pty Ltd

INN (International namn):

normal immunoglobulin

Läkemedelsform:

Injection, solution

Sammansättning:

Excipient Ingredients: maltose

Administreringssätt:

Intravenous

Enheter i paketet:

50mL, 200mL

Klass:

Medicine Listed (Export Only)

Receptbelagda typ:

(S1) This Schedule is intentionally blank

Terapeutiska indikationer:

TBSF Human Immunoglobulin for Intravenous Use is indicated for replacement IgG therapy in: * primary immunodeficiency (PID) * symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. TBSF Human Immunoglobulin for Intravenous Use is indicated for immunomodulatory therapy in: * Idiopathic Thrombocytopenic Purpura (ITP), in adults or children at high risk of bleeding or prior to surgery to correct the platelet count * allogeneic bone marrow transplantation * Kawasaki disease * Guillain-Barre Syndrome (GBS).

Produktsammanfattning:

Visual Identification: Clear, colourless solution; Container Type: Vial; Container Life Time: 3 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Bemyndigande status:

Listed (Export Only)

Tillstånd datum:

2006-03-01